Home>Topics>Stocks>Ariad Pharmaceuticals

Ariad Pharmaceuticals

  1. All
  2. Headlines
  1. UPDATE 2-Ariad Pharma CEO Berger to retire in deal with top investor

    Headlines

    Wed, 29 Apr 2015

    April 29 (Reuters) - Ariad Pharmaceuticals Inc said Chief Executive Harvey Berger would retire as part of a deal to settle a proxy battle with its largest shareholder Sarissa Capital Management.

  2. Ariad CEO Berger to step down in settlement deal with Sarissa

    Headlines

    Wed, 29 Apr 2015

    April 29 (Reuters) - Sarissa Capital Management LP said Ariad Pharmaceuticals Inc's Harvey Berger would retire as CEO as part of a deal to settle the hedge funds's proxy battle with the drugmaker.

  3. Ariad adopts rights plan to protect tax assets

    Headlines

    Fri, 1 Nov 2013

    Nov 1 (Reuters) - Ariad Pharmaceuticals Inc adopted a shareholder rights plan to protect its tax credits, a day after sales of its flagship drug Iclusig were suspended due to safety concerns...

  4. Ariad shares fall as FDA panel fails to back cancer drug

    Headlines

    Wed, 21 Mar 2012

    (Reuters) - Ariad Pharmaceuticals ' shares fell 3 percent on Wednesday morning after a U.S. Food and Drug Administration panel did not recommend the company's experimental cancer candidate.

Content Partners